Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

BOLTBOLT
5 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in BOLT BIOTHERAPEUTICS INC

Yes. JPMorgan Chase holds 42 shares of BOLT (Bolt Biotherapeutics), worth $165, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. JPMorgan Chase has held BOLT since Q2 2025, across 5 quarterly 13F filings.

Current Value

$165

Current Shares

42

Total Value Change

-$86

Total Shares Change

-1

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
42
0.0%
$1650.0%$3.85
0
2026-Q1
Unchanged
42
0.0%
$1790.0%$4.04
0
2025-Q4
Unchanged
42
0.0%
$2300.0%$5.47
0
2025-Q3
Decreased
42
-2.3%
$2230.0%$5.32
0
2025-Q2
New
43
-
$2510.0%$5.77
17

Other major holders of BOLT: RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used